Evidence map›Paper›PMID 26160825›Full record

ArticleStatistical methods in medical research2017

Estimating the ratio of multivariate recurrent event rates with application to a blood transfusion study.

Jing Ning, Mohammad H Rahbar, Sangbum Choi, Jin Piao, Chuan Hong, Deborah J Del Junco, Elaheh Rahbar, Erin E Fox, John B Holcomb, Mei-Cheng Wang

Open access · greenAbstract read
In one paragraph

Article in Statistical methods in medical research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Jing Ning1 Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, USA.
Mohammad H Rahbar2 Division of Clinical and Translational Sciences, Department of Internal Medicine, The University of Texas Medical School at Houston, Houston, USA.
Sangbum Choi2 Division of Clinical and Translational Sciences, Department of Internal Medicine, The University of Texas Medical School at Houston, Houston, USA.
Jin Piao4 Division of Biostatistics, School of Public Health, The University of Texas Health Sciences Center at Houston, Houston, USA.
Chuan Hong4 Division of Biostatistics, School of Public Health, The University of Texas Health Sciences Center at Houston, Houston, USA.
Deborah J Del Junco5 Center for Translational Injury Research, Division of Acute Care Surgery, Department of Surgery, The University of Texas Health Science Center at Houston, Houston, USA.
Elaheh Rahbar6 Department of Biomedical Engineering, Wake Forest University, Winston-Salem, USA.
Erin E Fox5 Center for Translational Injury Research, Division of Acute Care Surgery, Department of Surgery, The University of Texas Health Science Center at Houston, Houston, USA.
John B Holcomb5 Center for Translational Injury Research, Division of Acute Care Surgery, Department of Surgery, The University of Texas Health Science Center at Houston, Houston, USA.
Mei-Cheng Wang7 Department of Biostatistics, School of Public Health, Johns Hopkins University, Baltimore, USA.
The University of Texas Health Science Center at Houston · USJohns Hopkins University · USThe University of Texas MD Anderson Cancer Center · USWake Forest University · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Center for Clinical and Translational Sciences (CCTS)UL1TR000371 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2012 to 2016
$13.4M
Statistical Methodology Development in Blood Transfusion Protocol ResearchR21HL109479 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI NING, JING, RAHBAR, MOHAMMAD HOSSEIN · 2013 to 2014
$418k
NCATS NIH HHS UL1 TR000371NCI NIH HHS P30 CA016672NHLBI NIH HHS R21 HL109479
6 · The paper itself

Abstract

In comparative effectiveness studies of multicomponent, sequential interventions like blood product transfusion (plasma, platelets, red blood cells) for trauma and critical care patients, the timing and dynamics of treatment relative to the fragility of a patient's condition is often overlooked and underappreciated. While many hospitals have established massive transfusion protocols to ensure that physiologically optimal combinations of blood products are rapidly available, the period of time required to achieve a specified massive transfusion standard (e.g. a 1:1 or 1:2 ratio of plasma or platelets:red blood cells) has been ignored. To account for the time-varying characteristics of transfusions, we use semiparametric rate models for multivariate recurrent events to estimate blood product ratios. We use latent variables to account for multiple sources of informative censoring (early surgical or endovascular hemorrhage control procedures or death). The major advantage is that the distributions of latent variables and the dependence structure between the multivariate recurrent events and informative censoring need not be specified. Thus, our approach is robust to complex model assumptions. We establish asymptotic properties and evaluate finite sample performance through simulations, and apply the method to data from the PRospective Observational Multicenter Major Trauma Transfusion study.

Indexed as

Blood TransfusionHemorrhageHumansMonte Carlo MethodMultivariate AnalysisObservational Studies as TopicProspective StudiesInformative censoringmultivariate recurrent eventrate ratiotransfusion medicine

Identifiers

PMID26160825
PMCPMC5088066
OpenAlexW2402105727

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.